Talk:JUPITER trial

This is the talk page for discussing improvements to the JUPITER trial article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

This article was nominated for deletion on 21 June 2009 (UTC). The result of the discussion was keep.

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Medicine: Cardiology C‑class Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
C	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Cardiology task force (assessed as Low-importance).
	This article has been marked as needing an infobox.
	An editor has requested that an image or photograph be added to this article.

A fact from JUPITER trial appeared on Wikipedia's Main Page in the Did you know column on 28 January 2009, and was viewed approximately 54 times (disclaimer) (check views). The text of the entry was as follows:

Did you know... that results from the JUPITER trial indicated that rosuvastatin may lower the relative risk of heart attacks and stroke in patients with normal cholesterol levels?

A record of the entry may be seen at Wikipedia:Recent additions/2009/January.

Wikipedia

Interesting...

"Because half of all vascular events occur in patients with normal or low levels of LDL cholesterol"

How is it this little fact isn't better known?! Maury Markowitz (talk) 12:47, 22 January 2009 (UTC)[reply]

That "half of all vascular events occur in patients with normal or low levels of LDL cholesterol", if true, is not altogether surprising. If, let us say, 70% of the population has a normal or low LDL level and these contribute to 50% of all vascular events, then the remaining 30% of patients (that is, those with elevated LDL levels) would be contributing 50% of the vascular events - a disproportionate number. The apparently large contribution of vascular events by those with normal LDL levels would be occurring, at least in great part, by the relative large number of people in this group. In this example with assumed figures, LDL elevation results in a doubling of risk. That is what elevated LDL cholesterol is about. However, because of the large number of people in the "normal" group, it is reasonable to try to determine whether treating them by further lowing their LDL cholesterol (or by another intervention) could lower their risk for vascular events, 58.173.8.24 (talk) 13:43, 13 April 2009 (UTC)[reply]